Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
120,538,577
-
Total 13F shares
-
2,612,910
-
Share change
-
+9,829
-
Total reported value
-
$7,543,000
-
Price per share
-
$2.89
-
Number of holders
-
11
-
Value change
-
-$15,648
-
Number of buys
-
5
-
Number of sells
-
5
Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value (RVPH) as of Q4 2021
As of 31 Dec 2021 REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value (RVPH) had 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,612,910 shares of stock of the company.
Largest 10 holders included TANG CAPITAL MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, EMC Capital Management, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., NORTHERN TRUST CORP, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, and Tower Research Capital LLC (TRC).
This table shows 11 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.